Background: Limited data exist describing the perceived strength of evidence behind practices to prevent common health care-associated infections (HAIs). We conducted a national survey of infection prevention personnel to assess perception of the evidence for various preventive practices. We were also curious whether lead infection preventionist certification in infection prevention and control (CIC) correlated with perceptions of the evidence. Methods: In 2009, we mailed surveys to 703 infection prevention personnel using a national random sample of US hospitals and all Veterans Affairs hospitals; the response rate was 68%. The survey asked the respondent to grade the strength of evidence behind prevention practices. We considered "strong" evidence as being 4 and 5 on a Likert scale. Multivariable logistic regression models assessed associations between CIC status and the perceived strength of the evidence. Results: The following practices were perceived by 90% or more of respondents as having strong evidence: alcohol-based hand rub, aseptic urinary catheter insertion, chlorhexidine for antisepsis prior to central venous catheter insertion, maximum sterile barriers during central venous catheter insertion, avoiding the femoral site for central venous catheter insertion, and semirecumbent positioning of the ventilated patient. CIC status was significantly associated with the perception of the evidence for several practices. Conclusion: Successful implementation of evidence-based practices should consider how key individuals in the translational process assess the strength of that evidence.
Preventing health care-associated infection (HAI) enhances patient safety. There has been a recent proliferation of guidelines, systematic reviews, meta-analyses, and other evidence-based recommendations that clinicians and policy makers can use to decide which HAI preventive practices to implement in their hospitals. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Whereas the availability of such information is helpful, it is important to understand how those who might champion HAI prevention activities in the hospital view the recommendations that are being provided. For instance, if a practice is perceived as being supported by weak evidence by those in a position to affect change among front-line health care personnel, uptake and implementation of this practice is unlikelydirrespective of the underlying strength of the evidence. 11 Infection preventionists (IPs) play a key role in preventing HAI within US hospitals. Every US hospital is required to comply with a condition of participation issued by the Centers for Medicare and Medicaid Services (CMS) stating that each hospital must designate a person(s) who serves as the IP to develop and implement policies and practices aimed at prevention and control of infections and communicable diseases. 12 IPs are not only expected to keep up with the prevention literature and make recommendations as to what practices to use to prevent infection, they may lead hospital efforts to implement the practice for routine use by front-line health care personnel. In this manner, IPs are a key link in the diffusion of innovation process by taking recommendations from the scientific literature and implementing certain recommendations in their facility. 13 For example, Furuya et al recently found that a central venous catheter (CVC) bundle was associated with a lower infection rate only when compliance with bundle elements was high. 14 Despite the importance of IPs in helping ensure the safety of hospitalized patients, little is known about how infection prevention personnel responsible for implementing infection prevention practices perceive the strength of evidence behind these practices. By identifying which preventive practices are believed to have strong, moderate, or weak evidence, we can better tailor implementation strategies in actual clinical settings to address such perceptions. As a secondary goal, we sought to determine whether CIC status influences the perceived strength of evidence for various infection prevention practices.
METHODS
We conducted a national survey study to compare the use of specific infection prevention practices by US hospitals. In March 2009, using a national sample of non-federal and all Veterans Affairs (VA) hospitals, we surveyed infection prevention personnel to understand how they rated the evidence for general infection prevention practices and specific practices to prevent catheterassociated urinary tract infection (CAUTI), central line-associated bloodstream infection (CLABSI), and ventilator-associated pneumonia (VAP). The study sample had been originally derived for a similar survey study conducted in 2005. 18 we sent an initial mailing, a reminder letter, and a second mailing of the survey after 4 weeks to those who had not yet responded. A third survey mailing was added in 2009 due to a lower response to the first two mailings, which had occurred contemporaneous with H1N1 preparations. All mailings were addressed to the ''Infection Control Coordinator'' with the following instructions for survey completion: if there were more than 1 IP at that particular facility, then the IP who supervises and/or coordinates the other IPs should complete the survey. If an IP was unavailable, the survey should be completed by someone involved in infection prevention such as a hospital epidemiologist, the chair of the infection control committee, or the chief of nursing. The University of Michigan and VA Ann Arbor Healthcare System provided institutional review board approval.
Study measures
The survey asked about the perception of the evidence for use of general infection prevention practices and practices specific to the prevention of CAUTI, CLABSI, and VAP in adult acute care patients, with attention directed to practices identified in published guidelines or recommendations from the Centers for Disease Control and Prevention (CDC) or professional associations. 2, 4, 6, 9, 19, 20 Using a Likert scale from 1 to 5 (1 being no evidence and 5 extremely strong evidence), respondents were asked to rate how strong they thought the evidence was for specific infection prevention practices. For our descriptive analysis, we categorized responses of 1 or 2 to correspond to "weak" evidence, responses of 3 to "moderate" evidence, and responses of 4 or 5 to "strong" evidence. For our regression analysis, strong evidence was defined as receiving a rating of 4 or 5. The perceptions of the evidence for all practices examined were dichotomized into binary dependent variables, with strong evidence (as defined above) coded as 1 and 0 otherwise. Information about general hospital characteristics and the infection control program were also collected, including whether the facility was participating in an infection prevention-related collaborative. Participation in a collaborative is measured as a "yes" response to the question "Is your facility involved in a collaborative effort to reduce health care-associated infections?" We also collected data on the number of full-time equivalent IPs, whether the lead IP is CIC, and the number of years the lead IP has been in current infection prevention position. The number of hospital beds was obtained from the AHA Database for fiscal year 2007 and was dichotomized as 250 beds or <250 beds for each hospital.
Statistical analysis
Means and standard deviations for continuous variables, and frequencies and percentages for categorical variables, were used to summarize selected hospital and IP characteristics. Descriptive statistics were used to generate frequency distributions of the perception of evidence for the infection prevention practices investigated. We used covariate adjusted logistic regression to examine multivariable associations between the CIC status of the lead IP and the perceived strength of the evidence for use of the various infection prevention practices. The following covariates were included in our final adjustment model: the number of years the respondent has been in their current position, the number of full-time equivalent IPs, hospital bed size, and hospital participation in a collaborative focused on reducing HAI. All analyses were conducted using Stata version 11.0 (Stata Corp, College Station, TX).
RESULTS
A total of 478 hospitals responded for an overall response rate of 68%. Demographic characteristics of the respondent hospitals are outlined in Table 1 . Whereas our respondents had a number of different job titles, the most frequently identified titles were IP (60%), various infection prevention-related leadership titles such as director of infection prevention (23%), and infection control and/or employee health nurse (11%). The remainder listed a number of miscellaneous titles (eg, nurse manager, risk manager, hospital epidemiologist, director of quality).
We first provide descriptive results for perception of evidence divided into the following sections: general infection prevention practices, CAUTI, CLABSI, and VAP. We then provide multivariable associations between perception of evidence and respondent characteristics focusing on the IP's CIC status.
General infection prevention practices
Nearly all respondents believe that hand hygiene with alcoholbased hand wash has strong evidence to support its use (Fig 1) . Antimicrobial stewardship programs also were perceived as having strong or moderate evidence supporting their use by 97% of respondents. Support for infection prevention practices focusing on preventing methicillin-resistant Staphylococcus aureus had more modest support.
CAUTI prevention practices
Among practices to prevent CAUTI (Fig 2) , respondents believed the evidence supporting aseptic insertion technique was the strongest, followed by timely removal of the urinary catheter (utilizing either a urinary catheter reminder or stop order) or a nurse-initiated removal protocol. Bladder ultrasound scanning also was perceived as having reasonably strong supporting evidence, as was the use of intermittent catheterization. The perceived strength of evidence supporting condom catheters in men and antimicrobial urinary catheters, on the other hand, was much lower.
CLABSI prevention practices
Among respondents, 90% or more IPs perceived the strength of evidence supporting the following practices as strong: chlorhexidine gluconate for insertion site skin antisepsis, maximum sterile barriers during CVC insertion, and avoiding the femoral site for central venous catheterization (Fig 3) . The perceived strength of evidence supporting the use of chlorhexidine sponge dressings at site of CVC insertion was less strong. The evidence supporting the use of antimicrobial catheters was perceived as moderate. Routine CVC changes were perceived as having weak evidence.
VAP prevention practices
Semirecumbent positioning was perceived as having strong evidence for preventing VAP by 97% of respondents, followed by "sedation vacation" (88%), antimicrobial mouth rinse (68%), and subglottic secretion drainage (59%) (Fig 4) . Other practicesd oscillating/kinetic beds, topical and/or systemic antibiotics for selective digestive tract decontamination, and silver-coated endotracheal tubesdwere perceived as having less strength of evidence.
CIC status
Having an IP with CIC was associated with a 2-fold increase in the odds of reporting strong perception of the evidence for antimicrobial stewardship programs (P ¼ .02) ( Table 2) . Furthermore, several significant associations were found between CIC status and perceived strength of evidence for device-specific HAIs. Within CAUTI, CIC status was associated with a 2-fold increase in the odds of reporting strong perception of evidence for nurse-initiated urinary catheter discontinuation protocols (P ¼ .01). Among CLABSI prevention activities, having an IP CIC was associated with approximately a 40% decreased odds of reporting strong perception of evidence for routine CVC changes (P ¼ .001). Finally, within VAP prevention, having an IP CIC was associated with approximately a 45% and 55% decreased odds of reporting strong perception of evidence for oscillating/kinetic beds (P ¼ .002) and for antimicrobial mouth rinse (P ¼ .03), respectively. CIC status was also associated with nearly a 3-fold increase in the odds of reporting strong perception of evidence for "sedation vacation" (P ¼ .01).
DISCUSSION
Given the clinical and economic consequences of HAI, several organizations and government agencies have issued guidelines for preventing infectious episodes in hospitalized patients. The US government has further incentivized hospitals to enhance the safety of their patients through infection prevention because CMS no longer reimburses hospitals for the additional costs of caring for patients who develop certain infections during hospitalization. 22 To reach their fullest potential for impact, however, guidelines should be implemented into everyday practice by taking into account the contextual factors at each hospital, including such factors as perceived strength of evidence supporting the use of a particular practice. 23 Through our national survey of hospitals, we provide data that can be used by clinicians and policy makers to guide infection prevention strategies. Our primary findings are 2-fold. First, our respondents, who are primarily IPs, appear to have general agreement about which practices have strong or weak evidence supporting their use to prevent HAI. We found that 90% or more of respondents believed that the following practices had strong evidence supporting their use: alcohol-based hand rub, aseptic urinary catheter insertion technique, chlorhexidine gluconate for skin antisepsis, maximum sterile barriers during catheter insertion, avoiding the femoral site for catheter insertion, and semirecumbent positioning of the ventilated patient. Second, CIC status was associated with strong perceived strength of evidence for several practices. This finding corresponds with our previously reported results that CIC status is associated with a higher likelihood of implementing certain infection prevention practices. 11, 16, 17 Others have found that the incidence of bloodstream infections caused by multidrug-resistant organisms such as methicillin-resistant S aureus are lower at facilities where at least 1 of the IPs is CIC. 24 CIC status may thus accelerate the implementation of preventive strategies, but additional studies are needed before making this conclusion firm.
In general, perceived strength of evidence tracked with the actual strength of evidence that has been reported in evidencebased guidelines. We will discuss these below for each HAI after first discussing the perceived importance of hand hygiene. Respondents believed that hand hygiene using alcohol-based hand rub had the strongest strength of evidence among all the practices queried. This is not surprising given that both the World Health Organization and the US CDC emphasize improving health care worker hand hygiene, as do several noted infection prevention authorities. [25] [26] [27] [28] For the CAUTI prevention practices surveyed, perceived strength of the evidence is generally in line with the strength of recommendation for the practices as assigned by the CDC Hospital Infection Control Practices Advisory Committee (HICPAC) guideline, 2 which is based on an algorithm incorporating the quality of evidence and whether it is already an accepted practice without harms noted. For example, the practices of aseptic insertion and catheter removal reminders or protocols are both a "IB" category recommendation in the HICPAC guideline (IB defined as "strong recommendation supported by low-quality evidence suggesting net clinical benefits or is an accepted or established practice (eg, aseptic technique) supported by low to very low or no quality evidence"). However, even though more respondents assessed the evidence for aseptic insertion as strongest (and as having stronger evidence than for removal using reminders or stop orders), there is actually little evidence available regarding the benefit of aseptic insertion of urinary catheters 29 dor the strength of association between increased use of aseptic technique with reduced CAUTI ratesdalthough it is a standard practice and consistent with general principles of preventing deviceassociated infection. In contrast, several studies have demonstrated reduced catheter use and/or CAUTI rates with use of catheter reminders or stop orders. 7 Regarding CLABSI, the 2011 updated HICPAC "Guidelines for the Prevention of Intravascular Catheter-Related Infections" highlight evidence-based practices proven to decrease the risk of this adverse outcome.
1 Importantly, the guidelines endorse the performance of specific practices in tandem (or "bundling") as a vehicle for reducing the burden of this HAI. 30 In our survey, we found that most respondents correctly recognized elements comprising the CLABSI bundle (eg, hand hygiene by the provider prior to insertion, use of maximal sterile barrier precautions, chlorhexidine for skin antisepsis, and avoidance of the femoral vein for site of insertion) as being supported by strong evidence. However, we found some important variations. For example, about one-third of respondents indicated that routine CVC changes had moderate or strong evidence supporting its use. On the contrary, several randomized trials have found this practice not to be beneficial. 31, 32 In fact, routine changes over guidewires have been associated with a trend toward increased risk of CLABSI. 33 For VAP, the 2008 compendium "Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals" is the most recent summary of evidence-based practices relevant to prevention of VAP. 20 In our survey, we found that some but not all of the practices that respondents thought were associated with the strongest evidence base, such as semirecumbent positioning, sedation vacation, antimicrobial mouth rinse, and subglottic secretion drainage, were concordant with the guidelines recommendations. Semirecumbent positioning had a "B" recommendation indicating moderate strength of evidence, as did subglottic secretion drainage and sedation vacation, whereas antiseptic mouth rinse had an "A" recommendation. Practices not recommended in the guideline, such as routine use of oscillating/kinetic beds, were generally perceived by respondents to have less than strong evidence supporting its use. The finding that the silvercoated endotracheal tubes were perceived to have the weakest strength of evidence supporting their use may also stem from the fact that the study results assessing the efficacy of the silver-coated tube 34 were reported after the publication of the guideline.
Importantly, the evidence base supporting VAP preventive practices appears to be substantially less robust than that for CLABSI as highlighted in a recent article. 21 CIC has been adopted as the centerpiece of a new competency model developed by the Association for Professionals in Infection Control & Epidemiology (APIC). 35 The rationale for this direction is derived from the identification and ongoing updates of core competencies addressed by CIC and emerging appreciation of the value this brings to patient safety. In general, we found that CIC appeared to correlate with strength of evidence for several of the HAI-specific practices. Our study has a number of important limitations. First, because the response rate was less than 100%, our results have some susceptibility to nonresponse bias. If the nonrespondents were systematically different from those responding, generalizing our results to the full population of US hospitals may not be possible. Second, we relied on self-reported data from 1 respondent, generally the lead IP, at each hospital to determine the perceived strength of evidence for the various infection prevention practices used, and it is possible that the perceptions of this individual may not reflect those of other infection prevention personnel working in the same facility. Third, in a small proportion of hospitals, someone other than an IP filled out the survey, such as a nurse manager or a hospital epidemiologist. Their perceptions may differ from that of the IP at that particular hospital. Fourth, decisions regarding the implementation of infection control practices are often made by multidisciplinary groups. Thus, factors beyond the perception of the strength of evidence may be relevant in choosing whether or not to implement a certain practice. Finally, participating in multistate or national collaboratives with designated (or even mandated) interventions 36, 37 may influence perception of the strength of evidence. Despite these limitations, our findings may help inform hospital epidemiologists, clinicians, policy makers, and decision makers about how best to implement evidence-based recommendations within infection prevention. Specifically, implementation has both technical aspects as well as socio-adaptive components. 13 Whereas the actual strength of the evidence is a technical issue, the perception of the strength of that evidence falls within the socioadaptive realm. Front-line clinicians and IPs primarily react to their perceived strength of the evidence because that is most immediate. Ideally, implementation scientists will focus not just on the strength of the evidence but how that evidence is perceived by the end-user. Those who develop guidelines should consider how to incorporate new evidence in a timely manner and modify recommendations accordingly. 
